FI903366A0 - Foerfarande foer framstaellning av en mycket ren icke infektioes antihemofilifaktor genom kromatografi. - Google Patents

Foerfarande foer framstaellning av en mycket ren icke infektioes antihemofilifaktor genom kromatografi.

Info

Publication number
FI903366A0
FI903366A0 FI903366A FI903366A FI903366A0 FI 903366 A0 FI903366 A0 FI 903366A0 FI 903366 A FI903366 A FI 903366A FI 903366 A FI903366 A FI 903366A FI 903366 A0 FI903366 A0 FI 903366A0
Authority
FI
Finland
Prior art keywords
kromatografi
infektioes
antihemofilifaktor
mycket
icke
Prior art date
Application number
FI903366A
Other languages
English (en)
Inventor
Andrew Smith
Original Assignee
Octapharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8199529&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI903366(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Octapharma Ag filed Critical Octapharma Ag
Publication of FI903366A0 publication Critical patent/FI903366A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Intermediate Stations On Conveyors (AREA)
  • Chemical Vapour Deposition (AREA)
FI903366A 1988-11-05 1990-07-04 Foerfarande foer framstaellning av en mycket ren icke infektioes antihemofilifaktor genom kromatografi. FI903366A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP88118478A EP0367840B1 (de) 1988-11-05 1988-11-05 Verfahren zur Herstellung eines hochreinen, nicht infektiösen Antihämophiliefaktors mittels Chromatographie
PCT/EP1989/001247 WO1990005140A1 (de) 1988-11-05 1989-10-19 Verfahren zur herstelung eines hochreinen, nicht infektiösen antihämophiliefaktors mittels chromatographie

Publications (1)

Publication Number Publication Date
FI903366A0 true FI903366A0 (fi) 1990-07-04

Family

ID=8199529

Family Applications (1)

Application Number Title Priority Date Filing Date
FI903366A FI903366A0 (fi) 1988-11-05 1990-07-04 Foerfarande foer framstaellning av en mycket ren icke infektioes antihemofilifaktor genom kromatografi.

Country Status (8)

Country Link
EP (1) EP0367840B1 (fi)
JP (1) JPH03502200A (fi)
AT (1) ATE85221T1 (fi)
DE (1) DE3878245D1 (fi)
DK (1) DK161590D0 (fi)
ES (1) ES2053684T3 (fi)
FI (1) FI903366A0 (fi)
WO (1) WO1990005140A1 (fi)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4008852A1 (de) * 1990-03-20 1991-09-26 Octapharma Ag Verfahren zur herstellung von nicht-infektioesem blutplasma
IT1248723B (it) * 1990-06-12 1995-01-26 Scalvo S P A Processo per la purificazione del fattore viii e fattore viii ottenuto con tale processo
FR2681867B1 (fr) * 1991-09-26 1993-12-31 Pasteur Merieux Serums Vaccins Procede de purification du facteur viii et preparations obtenues.
DE4204694C3 (de) * 1992-02-01 1995-10-12 Octapharma Ag Verfahren zur Gewinnung von hochreinem, virusinaktiviertem Faktor VIII mittels Anionenaustauscher-Chromatographie
AT399818B (de) * 1992-04-24 1995-07-25 Immuno Ag Verfahren zur herstellung einer hochgereinigten virussicheren faktor viii-präparation
IT1256622B (it) * 1992-12-04 1995-12-12 Sclavo Spa Processo per l'estrazione del complesso fattore viii-fattore von willebrand (fviii:c-fvw) da plasma umano totale.
CA2155337A1 (en) * 1993-02-09 1994-08-18 Monika Stadler Method for inactivating viruses devoid of lipid envelopes
SE9301582D0 (sv) * 1993-05-07 1993-05-07 Kabi Pharmacia Ab Purification of plasma proteins
DE4337573C1 (de) * 1993-11-04 1995-05-18 Octapharma Ag Verfahren zur Herstellung einer virusinaktivierten Faktor VIII enthaltenden Fraktion mittels chromatographischer Methoden
AT407159B (de) † 1997-06-13 2001-01-25 Immuno Ag Verfahren zur abreicherung von viralen und molekularen pathogenen aus einem biologischen material
AU5678500A (en) * 1999-06-08 2000-12-28 Octapharma Ag Process for removing viruses from biological samples
EP1148063A1 (de) 2000-04-18 2001-10-24 Octapharma AG Haemostatisch aktives vWF enthaltendes Präparat und Verfahren zu seiner Herstellung

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE713764A (fi) 1967-05-01 1968-09-16 Baxter Travenol Lab
JPS52125609A (en) 1976-04-09 1977-10-21 Green Cross Corp:The Purification of agglutination factor viii
DE2635894A1 (de) * 1976-08-10 1978-02-16 Biotest Serum Institut Gmbh Verfahren zur herstellung eines antihaemophiles globulin a enthaltenden konzentrats
US4386068A (en) * 1980-02-26 1983-05-31 Cutter Laboratories, Inc. Antihemophilic factor concentrate and method for preparation
US4495175A (en) 1982-08-05 1985-01-22 University Of Rochester Preparation of highly purified human antihemophilic factor
US4540573A (en) 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
US4478825A (en) * 1983-10-14 1984-10-23 Armour Pharmaceutical Company Warm ethanol method for preparation of low fibrinogen antihemophilic factor
US4508709A (en) * 1983-12-05 1985-04-02 Armour Pharmaceutical Company Process for purifying factor VIII:C
DE3432083A1 (de) 1984-08-31 1986-03-06 Behringwerke Ag, 3550 Marburg Pasteurisierte, isoagglutininfreie faktor viii-praeparation und verfahren zu ihrer herstellung
US4743680A (en) 1985-02-01 1988-05-10 New York University Method for purifying antihemophilic factor
ATE73820T1 (de) * 1986-03-27 1992-04-15 Octapharma Ag Verfahren zur herstellung eines hochgereinigten antihaemophilie-faktors.
US4789545A (en) 1986-03-31 1988-12-06 New York Blood Center, Inc. Removal of lipid soluble process chemicals from biological materials by extraction with naturally occurring oils or synthetic substitutes thereof
JPS63108000A (ja) * 1986-05-15 1988-05-12 Green Cross Corp:The 第８因子の精製方法
DE3878227D1 (de) 1988-05-27 1993-03-18 Centre Regional De Transfusion Verfahren zur herstellung eines hochreinen, virusfreien antihaemophiliefaktors mittels chromatographie.

Also Published As

Publication number Publication date
ATE85221T1 (de) 1993-02-15
DE3878245D1 (de) 1993-03-18
WO1990005140A1 (de) 1990-05-17
DK161590A (da) 1990-07-04
ES2053684T3 (es) 1994-08-01
EP0367840B1 (de) 1993-02-03
DK161590D0 (da) 1990-07-04
JPH03502200A (ja) 1991-05-23
EP0367840A1 (de) 1990-05-16

Similar Documents

Publication Publication Date Title
FI903366A0 (fi) Foerfarande foer framstaellning av en mycket ren icke infektioes antihemofilifaktor genom kromatografi.
ATE72121T1 (de) Verfahren zur herstellung von apolipoproteinen aus blutplasma- oder serumfraktionen.
DE68919466T2 (de) Verfahren zur Herstellung von schraubenförmigen, glasfaserverstärkten Befestigungselementen.
DE69013313D1 (de) Mehrstufenverfahren zur Herstellung von Hexafluorpropylen.
DE68915676D1 (de) Verfahren zur Herstellung von Linsen.
DE69101156D1 (de) Ein Verfahren zur Herstellung von veränderten adsorbierenden Kohlenstoffmolekularsieben.
PL286746A1 (en) Method of obtaining a complex of antihaemophilic globulin with the willebrand factor from whole blood plasma, in the form of concentrate
DE68916086T2 (de) Verfahren zur Herstellung von Kohlenstoff/Kohlenstoff-Verbundstoffen.
ES2147898T3 (es) Regeneracion de tamiz molecular que contiene titanio.
DE3880313T2 (de) RF-Plasmaverfahren zur Herstellung von mehrschichtigen verstärkten Verbundwerkstoffen.
DE69010171D1 (de) Mehrstufenverfahren zur Herstellung von Hexafluoropropylen.
ATE166881T1 (de) Verfahren zur herstellung von faktor viii
ATE131490T1 (de) Verfahren zur herstellung von gereinigten albuminlösungen
ATE78239T1 (de) Verfahren zur herstellung von zeolithen.
FI961900A (fi) Menetelmä virusinaktivoidun, tekijä-VIII-pitoisen fraktion valmistamiseksi kromatografisilla menetelmillä
DE9416814U1 (de) Vorrichtung zur Herstellung von Glasformlingen nach dem Preßverfahren
EP0281089A3 (en) Process for the preparation of factor viii:c deficient plasma, and deficient plasma obtained therwith
DE59208707D1 (de) Verfahren zur Reinigung von Streptolysin 0, intaktes Streptolysin 0 erhältlich nach diesem Verfahren und seine Verwendung
DE59005407D1 (de) Verfahren zur Herstellung von faserreaktiven Formazanverbindungen.
HU906946D0 (en) Process for producing pharmaceutical preparative containing n-methyl-2-(3-pyridyl)-tetrahydropyrane-2-carbothioamide-1-oxide applicable for treating insufficiency of coronary arteries
DE68918226D1 (de) Verfahren zur Herstellung von Indigoverbindungen.
AU5603886A (en) A process for the control of odours in a vapour stream
DE68918436T2 (de) Adsorptives Trennungsverfahren zur Reinigung von 2,6-Dimethylnaphthalin.

Legal Events

Date Code Title Description
FD Application lapsed
FD Application lapsed

Owner name: OCTAPHARMA AG